Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial
- PMID: 12503977
- DOI: 10.1001/jama.289.1.56
Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial
Abstract
Context: Sexual dysfunction is a common adverse effect of antidepressants that frequently results in treatment noncompliance.
Objective: To assess the efficacy of sildenafil citrate in men with sexual dysfunction associated with the use of selective and nonselective serotonin reuptake inhibitor (SRI) antidepressants.
Design, setting, and patients: Prospective, parallel-group, randomized, double-blind, placebo-controlled trial conducted between November 1, 2000, and January 1, 2001, at 3 US university medical centers among 90 male outpatients (mean [SD] age, 45 [8] years) with major depression in remission and sexual dysfunction associated with SRI antidepressant treatment.
Intervention: Patients were randomly assigned to take sildenafil (n = 45) or placebo (n = 45) at a flexible dose starting at 50 mg and adjustable to 100 mg before sexual activity for 6 weeks.
Main outcome measures: The primary outcome measure was score on the Clinical Global Impression-Sexual Function (CGI-SF); secondary measures were scores on the International Index of Erectile Function, Arizona Sexual Experience Scale, Massachusetts General Hospital-Sexual Functioning Questionnaire, and Hamilton Rating Scale for Depression (HAM-D).
Results: Among the 90 randomized patients, 93% (83/89) of patients treated per protocol took at least 1 dose of study drug and 85% (76/89) completed week 6 end-point assessments with last observation carried forward analyses. At a CGI-SF score of 2 or lower, 54.5% (24/44) of sildenafil compared with 4.4% (2/45) of placebo patients were much or very much improved (P<.001). Erectile function, arousal, ejaculation, orgasm, and overall satisfaction domain measures improved significantly in sildenafil compared with placebo patients. Mean depression scores remained consistent with remission (HAM-D score < or =10) in both groups for the study duration.
Conclusion: In our study, sildenafil effectively improved erectile function and other aspects of sexual function in men with sexual dysfunction associated with the use of SRI antidepressants. These improvements may allow patients to maintain adherence with effective antidepressant treatment.
Comment in
-
Sildenafil reduced antidepressant-associated sexual dysfunction in men with remitted major depressive disorder.ACP J Club. 2003 Sep-Oct;139(2):47. ACP J Club. 2003. PMID: 12954039 No abstract available.
-
Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial.J Urol. 2003 Aug;170(2 Pt 1):682-3. J Urol. 2003. PMID: 14601579 No abstract available.
Similar articles
-
Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.JAMA. 2008 Jul 23;300(4):395-404. doi: 10.1001/jama.300.4.395. JAMA. 2008. PMID: 18647982 Clinical Trial.
-
Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.J Clin Psychiatry. 2006 Feb;67(2):240-6. doi: 10.4088/jcp.v67n0210. J Clin Psychiatry. 2006. PMID: 16566619 Clinical Trial.
-
Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction.Int J Impot Res. 2007 Mar-Apr;19(2):167-75. doi: 10.1038/sj.ijir.3901502. Epub 2006 Jul 27. Int J Impot Res. 2007. PMID: 16871270 Clinical Trial.
-
Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression.Urology. 2002 Sep;60(2 Suppl 2):58-66. doi: 10.1016/s0090-4295(02)01691-6. Urology. 2002. PMID: 12414334 Review.
-
Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.Arch Intern Med. 2002 Jun 24;162(12):1349-60. doi: 10.1001/archinte.162.12.1349. Arch Intern Med. 2002. PMID: 12076233 Review.
Cited by
-
Effects of tadalafil on sexual behavior of male rats induced by chronic unpredictable mild stress.Sex Med. 2023 May 26;11(2):qfad019. doi: 10.1093/sexmed/qfad019. eCollection 2023 Apr. Sex Med. 2023. PMID: 37256219 Free PMC article.
-
Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Mar 2;3(3):e201423. doi: 10.1001/jamanetworkopen.2020.1423. JAMA Netw Open. 2020. PMID: 32196105 Free PMC article.
-
Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach.J Clin Med. 2019 Oct 7;8(10):1640. doi: 10.3390/jcm8101640. J Clin Med. 2019. PMID: 31591339 Free PMC article. Review.
-
Leaf-Methanolic Extract of Pseudopanax arboreus (Araliaceae) (L. F. Phillipson) Reverses Amitriptyline-Induced Sexual Dysfunction in Male Rats.Biochem Res Int. 2018 Nov 15;2018:2869727. doi: 10.1155/2018/2869727. eCollection 2018. Biochem Res Int. 2018. PMID: 30581624 Free PMC article.
-
The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.World Psychiatry. 2018 Feb;17(1):3-11. doi: 10.1002/wps.20509. World Psychiatry. 2018. PMID: 29352532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical